Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium Study. [electronic resource]
Producer: 20090917Description: 1149-55 p. digitalISSN:- 1432-0843
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Capecitabine
- Deoxycytidine -- administration & dosage
- Drug Therapy, Combination
- Female
- Fluorouracil -- administration & dosage
- Gene Expression -- drug effects
- Humans
- Leukocytes, Mononuclear -- drug effects
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neoplasm Metastasis -- drug therapy
- Neoplasms -- drug therapy
- Oligodeoxyribonucleotides -- administration & dosage
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Ribonucleoside Diphosphate Reductase -- antagonists & inhibitors
- Treatment Outcome
- Tumor Suppressor Proteins -- genetics
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.